Thermo Fisher Scientific, Inc. TMO

Thermo Fisher Scientific Inc. desarrolla, fabrica y vende una variedad de productos. La compañía opera a través de cuatro segmentos: Soluciones de Ciencias de la Vida, Instrumentos Analíticos, Diagnósticos Especiales y Productos y Servicios de Laboratorio. Ofrece sus productos y servicios a través de varias marcas, incluyendo Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific y Unity Lab Services. El segmento de Soluciones de Ciencias de la Vida proporciona un portafolio de reactivos, instrumentos y consumibles utilizados en la investigación biológica y médica, descubrimiento y producción de nuevos medicamentos y vacunas. El segmento de Instrumentos Analíticos ofrece una amplia gama de instrumentos, consumibles, software y servicios utilizados para diversas aplicaciones en el laboratorio. El segmento de Diagnósticos Especiales ofrece una amplia gama de kits de pruebas diagnósticas, reactivos, medios de cultivo, instrumentos y productos asociados. Su segmento de Productos y Servicios de Laboratorio ofrece productos y soluciones necesarios para el laboratorio.

Con 1 acción de TMO (USD 676,47) habrías recibido USD 1,84 en dividendos en los últimos 12 meses.

• Zacks Investment Research 5 oct

  Beat the Market Like Zacks: Thermo Fisher, Cricut, Shopify in Focus

  Zacks Research showcased strong performance across its various investment portfolios and rating systems during the week ended October 2, 2026. Multiple stocks received upgrades and delivered significant gains, including CRCT and PGEN surging 32% and 30.8% respectively following recommendation upgrades. The Zacks Rank #1 portfolio outperformed the S&P 500 by 2.3 percentage points year-to-date, while the Focus List portfolio returned 19.86% versus 13.14% for the S&P 500 through August 31, 2026.

  

• GlobeNewswire Inc. 5 oct

  Immunogenomics Market Size, Share, Trends, and Growth Forecast, 2026-2033 | NGS and Personalized Medicine Drive Market Toward USD 9.82 Billion at 5.97% CAGR

  The global immunogenomics market is projected to grow from USD 6.32 billion in 2025 to USD 9.82 billion by 2033, expanding at a CAGR of 5.97%. Growth is driven by advancements in next-generation sequencing technologies, increasing demand for personalized medicine, and rising prevalence of immune-related disorders. Key applications include oncology, infectious disease research, vaccine development, and autoimmune disorder studies, with adoption across hospitals, diagnostic laboratories, pharmaceutical companies, and academic institutions.

  

• GlobeNewswire Inc. 5 oct

  Global Oligonucleotide Synthesis Reagents Market Size, Share, and Forecast, 2026-2033 | Therapeutics Demand Fuels 11.9% CAGR and USD 1.75 Billion Opportunity

  The global oligonucleotide synthesis reagents market is valued at USD 723.3 million in 2025 and is projected to reach USD 1.75 billion by 2033, growing at a 11.9% CAGR. Growth is driven by increasing demand for nucleic acid-based therapeutics including siRNA, antisense oligonucleotides, CRISPR gene editing, and mRNA platforms across oncology, rare genetic disorders, and infectious diseases.

  

• GlobeNewswire Inc. 5 oct

  Cell and Gene Therapy Biomanufacturing Market - Size, Share, and Forecast, 2026-2031 | Automation, Viral Vectors, and CDMO Expansion Drive 11.7% CAGR to $8.7 Billion

  The global cell and gene therapy biomanufacturing market is projected to grow from $5.0 billion in 2026 to $8.7 billion by 2031, driven by an 11.7% CAGR. Growth is fueled by increasing regulatory approvals, rising demand for scalable manufacturing infrastructure, and investments in automation and modular systems. However, high production costs, regulatory complexity, and workforce shortages remain significant challenges.

  

• GlobeNewswire Inc. 5 oct

  Magnetic Beads Market - Global Forecast and Growth Opportunities, 2026-2032 | Automation, Genomics, and Molecular Diagnostics Drive 7.91% CAGR Toward USD 6.18 Billion

  The global magnetic beads market is projected to grow from USD 3.90 billion in 2026 to USD 6.18 billion by 2032, driven by automation, molecular diagnostics, genomics, and bioprocessing applications. Key growth drivers include adoption of automated magnetic separation platforms, advanced surface chemistries, AI-enabled workflow optimization, and expanding diagnostics capacity across regions. Strategic priorities for industry leaders include developing application-specific chemistries, strengthening supply-chain resilience, and leveraging AI analytics.